| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 673038 | 61462 | FENIVIR 10 mg/g CREMA | FENIVIR 10 mg/g CREMA, 1 tubo de 2 g | 10 mg/g | 44 | 2 | 21 | 1 tubo de 2 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61462/61462_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61462/61462_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28863 | PERRIGO ESPANA S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 672087 | 40309 | OFTALMOLOSA CUSI DEXAMETASONA 0,5 mg/g POMADA OFTÁLMICA | OFTALMOLOSA CUSI DEXAMETASONA 0,5 mg/g POMADA OFTÁLMICA , 1 tubo de 3 g | 0,5 mg/g | 44 | 3 | 21 | 1 tubo de 3 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/40309/40309_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/40309/40309_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33677 | LABORATORIOS FIDIA FARMACEUTICA S.L. | 1964-12-01 | 1 | 1 | 1 | 1964-12-01 | 2011-04-11 | 0 | 2011-10-17 | 797647, 653111, 656650, 656830 | View Edit Delete | |||||||||||
| 674945 | 62641 | CEFTRIAXONA NORMON 1000 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 1000 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 1.000 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62641/62641_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62641/62641_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674952 | 62640 | CEFTRIAXONA NORMON 500 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 500 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 500 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62640/62640_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62640/62640_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674960 | 62639 | CEFTRIAXONA NORMON 250 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 250 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 250 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62639/62639_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62639/62639_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674994 | 62636 | CEFTRIAXONA NORMON 500 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG | CEFTRIAXONA NORMON 500 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG, 1 vial + 1 ampolla de disolvente | 500 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62636/62636_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62636/62636_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 672784 | 73023 | REMIFENTANILO KERN PHARMA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | REMIFENTANILO KERN PHARMA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG , 5 viales | 1 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73023/73023_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73023/73023_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2010-11-17 | 1 | 1 | 1 | 2010-11-17 | 2010-11-17 | 0 | 2011-03-14 | Lista I | View Edit Delete | |||||||||||
| 672785 | 73025 | REMIFENTANILO KERN PHARMA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | REMIFENTANILO KERN PHARMA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG , 5 viales | 5 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73025/73025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73025/73025_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2010-11-17 | 1 | 1 | 1 | 2010-11-17 | 2010-11-17 | 0 | 2011-03-14 | Lista I | View Edit Delete | |||||||||||
| 672786 | 73024 | REMIFENTANILO KERN PHARMA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | REMIFENTANILO KERN PHARMA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG , 5 viales | 2 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73024/73024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73024/73024_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2010-11-17 | 1 | 1 | 1 | 2010-11-17 | 2010-11-17 | 0 | 2011-03-14 | Lista I | View Edit Delete | |||||||||||
| 672521 | 70886 | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 ml | 20 mg/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70886/70886_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70886/70886_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-05-04 | 1 | 1 | 1 | 2009-05-04 | 2010-08-30 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 672522 | 70886 | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 25 ml | 20 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70886/70886_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70886/70886_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-05-04 | 1 | 1 | 1 | 2009-05-04 | 2010-08-30 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 672501 | 61490 | ULTIVA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 5 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61490/61490_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61490/61490_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 672519 | 61489 | ULTIVA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 2 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61489/61489_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61489/61489_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 672527 | 61488 | ULTIVA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 1 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61488/61488_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61488/61488_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 674242 | 61380 | LEUSTATIN 1 MG/ML SOLUCION PARA PERFUSION | LEUSTATIN 1 MG/ML SOLUCION PARA PERFUSION , 7 viales de 10 ml | 1 mg/ml inyectable 10 ml | 45 | 7 | 34 | 7 viales de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61380/61380_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61380/61380_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35106 | PHARMANOVIA A/S | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 672240 | 72571 | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 20 viales de 25 mg | 25 mg | 45 | 20 | 34 | 20 viales de 25 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72571/72571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72571/72571_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44015 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2010-07-21 | 1 | 1 | 1 | 2010-07-21 | 2010-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 672241 | 72571 | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 5 viales de 100 mg | 100 mg | 45 | 5 | 34 | 5 viales de 100 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72571/72571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72571/72571_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44015 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2010-07-21 | 1 | 1 | 1 | 2010-07-21 | 2010-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673372 | 72609 | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 10 ml | 1 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72609/72609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72609/72609_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2012-03-14 | View Edit Delete | ||||||||||||
| 673770 | 72386 | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 40 ml | 5 mg/ml inyectable 40 ml | 45 | 1 | 34 | 1 vial de 40 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72386/72386_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72386/72386_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2011-03-16 | 1 | 2011-06-20 | View Edit Delete | ||||||||||||
| 672694 | 47396 | PENILEVEL RETARD 1.000.000 U.I. | PENILEVEL RETARD 1.000.000 U.I. , 1 vial + 1 ampolla de disolvente | 200.000 UI/600.000 UI/200.000 UI | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1969-03-01 | 1 | 1 | 1 | 1969-03-01 | 2011-03-29 | 0 | 2011-09-21 | 819177, 653435 | View Edit Delete |
Page 267 of 1035, showing 20 records out of 20697 total, starting on record 5321, ending on 5340